Tag: mantle cell lymphoma treatment
Acalabrutinib wins US FDA approval for mantle cell lymphoma treatment
Acalabrutinib FDA approval : AstraZeneca has secured an early approval for its blood cancer drug Calquence (acalabrutinib) for the treatment of mantle cell lymphoma in ... Read More